Human xenoreactive natural antibodies against Gal alpha (1-3) pig terminal residues are not produced by CD5+ B-lymphocytes.
Pitre
J
J
Department of Immunology, Microbiology, Pathology, and Infectious Diseases, Karolinska Institute, Huddinge Hospital, Sweden.
Möller
E
E
Satake
M
M
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis* / Q000276:immunology; D000917:Antibody Formation; D015703:Antigens, CD; D001402:B-Lymphocytes / Q000276:immunology*; D018956:CD5 Antigens; D002240:Carbohydrate Sequence; D004187:Disaccharides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D008969:Molecular Sequence Data; D013552:Swine
D000910:Antibodies, Heterophile; D015703:Antigens, CD; D018956:CD5 Antigens; D004187:Disaccharides; D007074:Immunoglobulin G; C055075:galactosyl-(1-3)galactose